Several in vitro studies investigated the effects of ATRA in combination with different other drugs in non-APL AML: for example, ATRA together with AZA has been shown to induce higher expression of CD11b in MLL-AF9-expressing AML cell lines (Fujiki et al., 2012). This evidence concerns the gene ITGAM and acute promyelocytic leukemia.